Clinical trial
Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn
NCT05006235 is registered in ClinicalTrials.gov with Ahmed Noaman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn
- Lead sponsor
- Ahmed Noaman
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 1, 2014
- Completion date
- December 31, 2015
- Enrollment
- 135 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.